Geron (GERN) Shares Outstanding (Diluted Average) (2020 - 2026)

Geron's (GERN) quarterly Shares Outstanding (Diluted Average) came in at $669375.0 in Q1 2026, up 0.52% year-on-year from $665905.0 in Q1 2025, and down 99.9% quarter-over-quarter from $666.7 million in Q4 2025.

Geron (GERN) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends

Geron has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $669375.0 for Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $669375.0, up 0.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $669375.0 (up 0.52% YoY), and the FY2025 annual result was $666.7 million, up 3.19% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $669375.0 for Q1 2026 at Geron, down from $666.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $667.1 million in Q3 2025 to a low of $665905.0 in Q1 2025.
  • The 5-year median for Shares Outstanding (Diluted Average) is $570.6 million (2023), against an average of $485.5 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) surged 63.96% in 2023 and tumbled 99.89% in 2025, its largest moves.
  • Geron's Shares Outstanding (Diluted Average) stood at $380.8 million in 2022, then soared by 49.86% to $570.6 million in 2023, then rose by 13.21% to $646.0 million in 2024, then climbed by 3.19% to $666.7 million in 2025, then slumped by 99.9% to $669375.0 in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $669375.0 (Q1 2026), $666.7 million (Q4 2025), and $667.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4,489.46 Bn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 810.00
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 118.76 Bn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 256.30 Mn
9 Abivax 95.45 Bn 95.45 Bn - 92.44 Mn
10 Geron 753,046.88 753,046.88 - 669,375.00

Historic Data

Download Data
DateValue
Mar 31, 2026 669,375.00
Dec 31, 2025 666.66 Mn
Sep 30, 2025 667.10 Mn
Jun 30, 2025 666.04 Mn
Mar 31, 2025 665,905.00
Dec 31, 2024 646.03 Mn
Sep 30, 2024 639.93 Mn
Jun 30, 2024 628.70 Mn
Mar 31, 2024 603.49 Mn
Dec 31, 2023 570.65 Mn
Sep 30, 2023 579.51 Mn
Jun 30, 2023 553.77 Mn
Mar 31, 2023 544.46 Mn
Dec 31, 2022 380.78 Mn
Sep 30, 2022 405.24 Mn
Jun 30, 2022 368.17 Mn
Mar 31, 2022 332.07 Mn
Dec 31, 2021 327.63 Mn
Sep 30, 2021 326.55 Mn
Jun 30, 2021 327.03 Mn